The Effect of Coronavirus Disease 2019 on Cardiovascular Diseases.
Clicks: 260
ID: 107699
2020
Article Quality & Performance Metrics
Overall Quality
Improving Quality
0.0
/100
Combines engagement data with AI-assessed academic quality
Reader Engagement
Steady Performance
66.7
/100
258 views
208 readers
Trending
AI Quality Assessment
Not analyzed
Abstract
Coronavirus disease 2019 (COVID-19) is a global pandemic affecting the world, seen in more than 1,300,000 patients. COVID-19 acts through the angiotensin-converting enzyme 2 (ACE2) receptor. Cardiovascular comorbidities are more common with COVID-19, and nearly 10% of cases develop myocarditis (22% of critical patients). Further research is needed to continue or discontinue ACE inhibitors and angiotensin receptor blockers, which are essential in hypertension and heart failure in COVID-19. Intensive research is promising for the treatment and prevention of COVID-19.
| Reference Key |
askin2020thearquivos
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Askin, Lutfu;Tanrıverdi, Okan;Askin, Husna Sengul; |
| Journal | arquivos brasileiros de cardiologia |
| Year | 2020 |
| DOI |
S0066-782X2020000600817
|
| URL | |
| Keywords | Keywords not found |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.